Cleared Traditional

K061311 - ALLOGRAN-R

K061311 is the FDA 510(k) clearance for ALLOGRAN-R by Biocomposites, Ltd.. It is a Class 2 Orthopedic device (product code MQV) cleared through the Traditional 510(k) pathway after a 135-day FDA review.

K061311 · Biocomposites, Ltd. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2006
Decision
135d
Days
Class 2
Risk

K061311 is an FDA 510(k) clearance for the ALLOGRAN-R. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Biocomposites, Ltd. (Keele, GB). The FDA issued a Cleared decision on September 22, 2006 after a review of 135 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Biocomposites, Ltd. devices

Submission Details

510(k) Number K061311 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 10, 2006
Decision Date September 22, 2006
Days to Decision 135 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
13d slower than avg
Panel avg: 122d · This submission: 135d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 259
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K061311.
INTEGRA MOZAIK BONE REGENERATION MATRIX - STRIPS
K063124 · Integra Lifesciences Corp. · Jan 2007
MOZAIK BONE REGENERATION MATRIX - PUTTY
K062353 · Integra LifeSciences Corporation · Dec 2006
HEALOS FX BONE GRAFT SUBSTITUTE AND GRAFT MIXING AND DELIVERY SYSTEM
K062495 · Depuy Spine, Inc. · Oct 2006
MODIFICATION TO ALLOMATRIX CUSTOM
K061939 · Wrightmedicaltechnologyinc · Jul 2006
NOVABONE PUTTY - BIOACTIVE SYNTHETIC GRAFT
K060728 · Novabone Products, LLC · May 2006
NOVABONE POROUS-BONE GRAFT SCAFFOLD
K060432 · Novabone Products, LLC · Apr 2006